Markets:

Overview

News

Currencies

International

Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

17.78 -0.01 (-0.06%)

Official Closing Price Updated: 7:00 PM EDT, Sep 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

30 31 Next >

Kenvue's Dual Dilemma: Tylenol and Talc Fears Trigger Sector Jitters

October 16, 2025

New York, NY – October 16, 2025 – The Consumer Staples and Healthcare sectors of the S&P 500 are experiencing a notable day of underperformance, largely overshadowed by the precipitous stock plunge of...

Via MarketMinute

Johnson & Johnson Plunges Amidst Escalating Talc Litigation: Billions at Stake as Legal Battles Intensify

October 16, 2025

New York, NY – October 16, 2025 – Johnson & Johnson (NYSE: JNJ), once considered a stalwart of stability, is currently navigating turbulent waters, finding itself among the market's bottom performers...

Via MarketMinute

Topics Bankruptcy Death Lawsuit

Kenvue (KVUE) Plunges Amidst Dual Headwinds: Tylenol Fears and Escalating Talc Litigation

October 16, 2025

Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has found itself at the bottom of today's market performance, with its stock price experiencing a significant decline. As...

Via MarketMinute

Topics Government Lawsuit

Discover which S&P500 stocks are making waves on Thursday. ↗

October 16, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.

Via Chartmill

These S&P500 stocks are the most active in today's session ↗

October 16, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

October 16, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Johnson & Johnson, Kenvue Named In First Ever UK Legal Action Over Talc Cancer Claims ↗

October 16, 2025

Johnson & Johnson faces 3,000 UK lawsuits alleging asbestos-contaminated talcum powder caused cancer and concealed risks for decades.

Via Benzinga

Topics Lawsuit

Johnson & Johnson Battles New UK Talc Cancer Claims Worth £1B After Massive US Verdict: Report ↗

October 15, 2025

Meanwhile, analysts raised price targets on the stock following strong Q3 results and the planned orthopedic spin-off.

Via Stocktwits

Topics Bankruptcy Death Lawsuit

2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 41% in 12 Months, According to Select Wall Street Analysts ↗

October 15, 2025

Juicy dividends are only part of the attraction with these beaten-down stocks.

Via The Motley Fool

Topics Government

Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AI

October 14, 2025

From Albert Invent

Via Business Wire

These S&P500 stocks are moving in today's session ↗

October 13, 2025

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Via Chartmill

Johnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To Watch ↗

October 13, 2025

Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as the next catalyst.

Via Benzinga

Tylenol Turmoil: Partisan Politics Fuel Confusion Over Pregnancy Risks, Poll Shows ↗

October 10, 2025

KFF poll shows falling trust in the CDC and HHS chief RFK Jr. as misinformation and partisan divides shape public views on vaccines.

Via Benzinga

Is This Beaten-Down Dividend King a Buy? ↗

October 10, 2025

This company's short life on the stock market has been a constant challenge.

Via The Motley Fool

Topics Intellectual Property

Which S&P500 stocks are moving on Thursday? ↗

October 09, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Stocks Ease, Delta Air Lines, Pepsi Jump On Strong Earnings: What's Moving Markets Thursday? ↗

October 09, 2025

U.S. stocks edged lower on Thursday, pausing after a record-setting run. The S&P 500 slipped 0.4% by midday in New York, retreating from an all-time high of 5,674 hit at the open.

Via Benzinga

Discover which S&P500 stocks are making waves on Thursday. ↗

October 09, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump ↗

October 08, 2025

One of these stocks lost about a quarter of its value in a single month.

Via The Motley Fool

Topics Government Stocks World Trade

Near 52-Week Low, Should You Buy Kenvue Stock? ↗

October 08, 2025

This beaten-down stock could be an attractive option for long-term investors.

Via The Motley Fool

Discover which S&P500 stocks are making waves on Tuesday. ↗

October 07, 2025

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Stocks, Bitcoin Slip, Gold Hits $4,000: What's Moving Markets Tuesday? ↗

October 07, 2025

Risk sentiment is taking a breather after days of a relentless rally, with all major Wall Street indexes trading in negative territory and sharper declines hitting the most speculative assets, such as...

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

October 07, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.

Via Chartmill

Why Is Kenvue Stock Falling, and Is It a Buying Opportunity? ↗

October 07, 2025

Investors are interested in this beaten-down business.

Via The Motley Fool

Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again ↗

October 06, 2025

While Kenvue's Tylenol has attracted intense political pressure, speculators are determined to make KVUE stock great again.

Via Benzinga

A Congress Member Sold Up To $330K In UnitedHealth Group Stock: Here's What You Need To Know ↗

October 06, 2025

Via Benzinga

Should You Buy Kenvue Stock After Its 30% Plunge? ↗

October 01, 2025

There hasn't been much good news lately for this Johnson & Johnson spinoff.

Via The Motley Fool

Topics Government Lawsuit

Cullen Trims KVUE Stake With $149.5M Share Sale ↗

October 01, 2025

Via The Motley Fool

Topics Regulatory Compliance

Friday's session: most active stock in the S&P500 index ↗

September 26, 2025

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for...

Via Chartmill

Demystifying Kenvue: Insights From 11 Analyst Reviews ↗

September 26, 2025

Kenvue (NYSE: KVUE) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings,...

Via Benzinga

White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend...' ↗

September 26, 2025

A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s claim that the drug is linked with autism in kids.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.